Perrino Brian A
Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV, USA.
J Neurogastroenterol Motil. 2016 Apr 30;22(2):213-25. doi: 10.5056/jnm15186.
An increase in intracellular Ca(2+) is the primary trigger of contraction of gastrointestinal (GI) smooth muscles. However, increasing the Ca(2+) sensitivity of the myofilaments by elevating myosin light chain phosphorylation also plays an essential role. Inhibiting myosin light chain phosphatase activity with protein kinase C-potentiated phosphatase inhibitor protein-17 kDa (CPI-17) and myosin phosphatase targeting subunit 1 (MYPT1) phosphorylation is considered to be the primary mechanism underlying myofilament Ca(2+) sensitization. The relative importance of Ca(2+) sensitization mechanisms to the diverse patterns of GI motility is likely related to the varied functional roles of GI smooth muscles. Increases in CPI-17 and MYPT1 phosphorylation in response to agonist stimulation regulate myosin light chain phosphatase activity in phasic, tonic, and sphincteric GI smooth muscles. Recent evidence suggests that MYPT1 phosphorylation may also contribute to force generation by reorganization of the actin cytoskeleton. The mechanisms responsible for maintaining constitutive CPI-17 and MYPT1 phosphorylation in GI smooth muscles are still largely unknown. The characteristics of the cell-types comprising the neuroeffector junction lead to fundamental differences between the effects of exogenous agonists and endogenous neurotransmitters on Ca(2+) sensitization mechanisms. The contribution of various cell-types within the tunica muscularis to the motor responses of GI organs to neurotransmission must be considered when determining the mechanisms by which Ca(2+) sensitization pathways are activated. The signaling pathways regulating Ca(2+) sensitization may provide novel therapeutic strategies for controlling GI motility. This article will provide an overview of the current understanding of the biochemical basis for the regulation of Ca(2+) sensitization, while also discussing the functional importance to different smooth muscles of the GI tract.
细胞内钙离子(Ca(2+))浓度升高是胃肠道(GI)平滑肌收缩的主要触发因素。然而,通过提高肌球蛋白轻链磷酸化来增加肌丝对Ca(2+)的敏感性也起着至关重要的作用。用蛋白激酶C增强的磷酸酶抑制蛋白-17 kDa(CPI-17)抑制肌球蛋白轻链磷酸酶活性以及肌球蛋白磷酸酶靶向亚基1(MYPT1)磷酸化被认为是肌丝Ca(2+)致敏的主要机制。Ca(2+)致敏机制对不同胃肠道运动模式的相对重要性可能与胃肠道平滑肌的不同功能作用有关。对激动剂刺激的反应中,CPI-17和MYPT1磷酸化的增加调节了相性、紧张性和括约肌胃肠道平滑肌中的肌球蛋白轻链磷酸酶活性。最近的证据表明,MYPT1磷酸化也可能通过肌动蛋白细胞骨架的重组促进力的产生。胃肠道平滑肌中维持组成型CPI-17和MYPT1磷酸化的机制在很大程度上仍然未知。构成神经效应器连接的细胞类型的特征导致外源性激动剂和内源性神经递质对Ca(2+)致敏机制的影响存在根本差异。在确定Ca(2+)致敏途径被激活的机制时,必须考虑肌层内各种细胞类型对胃肠道器官对神经传递的运动反应的贡献。调节Ca(2+)致敏的信号通路可能为控制胃肠道运动提供新的治疗策略。本文将概述目前对Ca(2+)致敏调节的生化基础的理解,同时也讨论其对胃肠道不同平滑肌的功能重要性。